Connection

Brett Froeliger to Humans

Back to Details
This is a "connection" page, showing publications Brett Froeliger has written about Humans.
Brett Froeliger
Connection Strength
0.508
Humans
  1. Associations between right inferior frontal gyrus morphometry and inhibitory control in individuals with nicotine dependence. Drug Alcohol Depend. 2023 03 01; 244:109766.
    View in: PubMed
    Score: 0.032
  2. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Sci Adv. 2019 10; 5(10):eaax1569.
    View in: PubMed
    Score: 0.025
  3. Impaired frontostriatal functional connectivity among chronic opioid using pain patients is associated with dysregulated affect. Addict Biol. 2020 03; 25(2):e12743.
    View in: PubMed
    Score: 0.025
  4. Reappraisal deficits promote craving and emotional distress among chronic pain patients at risk for prescription opioid misuse. J Addict Dis. 2018 Jan-Jun; 37(1-2):14-22.
    View in: PubMed
    Score: 0.023
  5. Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task. Drug Alcohol Depend. 2018 06 01; 187:13-21.
    View in: PubMed
    Score: 0.023
  6. Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability. JAMA Psychiatry. 2017 04 01; 74(4):379-386.
    View in: PubMed
    Score: 0.021
  7. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards. Psychother Psychosom. 2017; 86(2):111-112.
    View in: PubMed
    Score: 0.021
  8. Depressive symptoms and responses to cigarette pack warning labels among Mexican smokers. Health Psychol. 2016 May; 35(5):442-53.
    View in: PubMed
    Score: 0.020
  9. The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend. 2015 Nov 01; 156:234-242.
    View in: PubMed
    Score: 0.019
  10. Frontoparietal attentional network activation differs between smokers and nonsmokers during affective cognition. Psychiatry Res. 2013 Jan 30; 211(1):57-63.
    View in: PubMed
    Score: 0.016
  11. Smoking abstinence and depressive symptoms modulate the executive control system during emotional information processing. Addict Biol. 2012 May; 17(3):668-79.
    View in: PubMed
    Score: 0.015
  12. Nicotine withdrawal modulates frontal brain function during an affective Stroop task. Psychopharmacology (Berl). 2012 Apr; 220(4):707-18.
    View in: PubMed
    Score: 0.015
  13. Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis. Psychopharmacology (Berl). 2010 Jul; 210(4):577-83.
    View in: PubMed
    Score: 0.013
  14. Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl). 2009 Sep; 205(4):625-33.
    View in: PubMed
    Score: 0.012
  15. Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory. Exp Clin Psychopharmacol. 2009 Jun; 17(3):173-80.
    View in: PubMed
    Score: 0.012
  16. Effects of nicotine and depressive traits on affective priming of lateralized emotional word identification. Exp Clin Psychopharmacol. 2008 Aug; 16(4):293-300.
    View in: PubMed
    Score: 0.012
  17. Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. Nicotine Tob Res. 2007 Mar; 9(3):351-63.
    View in: PubMed
    Score: 0.011
  18. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation. Drug Alcohol Depend. 2022 Oct 01; 239:109596.
    View in: PubMed
    Score: 0.008
  19. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial. JAMA Intern Med. 2022 04 01; 182(4):407-417.
    View in: PubMed
    Score: 0.008
  20. Nicotine Metabolism Predicted by CYP2A6 Genotypes in Relation to Smoking Cessation: A Systematic Review. Nicotine Tob Res. 2022 03 26; 24(5):633-642.
    View in: PubMed
    Score: 0.008
  21. Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy. Drug Alcohol Depend. 2022 04 01; 233:109361.
    View in: PubMed
    Score: 0.007
  22. Neurophysiological Deficits During Reappraisal of Negative Emotional Stimuli in Opioid Misuse. Biol Psychiatry. 2022 06 15; 91(12):1070-1078.
    View in: PubMed
    Score: 0.007
  23. Translational Research in Nicotine Addiction. Cold Spring Harb Perspect Med. 2021 06 01; 11(6).
    View in: PubMed
    Score: 0.007
  24. A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation. Nicotine Tob Res. 2021 05 24; 23(6):983-991.
    View in: PubMed
    Score: 0.007
  25. An observational study and randomized trial of stress reactivity in cancer disparities. Health Psychol. 2020 Sep; 39(9):745-757.
    View in: PubMed
    Score: 0.007
  26. The temporal dynamics of emotion dysregulation in prescription opioid misuse. Prog Neuropsychopharmacol Biol Psychiatry. 2021 01 10; 104:110024.
    View in: PubMed
    Score: 0.007
  27. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial. J Consult Clin Psychol. 2019 Oct; 87(10):927-940.
    View in: PubMed
    Score: 0.006
  28. Effects of Mindfulness-Oriented Recovery Enhancement Versus Social Support on Negative Affective Interference During Inhibitory Control Among Opioid-Treated Chronic Pain Patients: A Pilot Mechanistic Study. Ann Behav Med. 2019 08 29; 53(10):865-876.
    View in: PubMed
    Score: 0.006
  29. An electronic, smart lighter to measure cigarette smoking: A pilot study to assess feasibility and initial validity. Addict Behav. 2019 11; 98:106052.
    View in: PubMed
    Score: 0.006
  30. Multi-method assessment of distress tolerance and smoking-related factors among adult daily smokers. Exp Clin Psychopharmacol. 2019 Apr; 27(2):136-145.
    View in: PubMed
    Score: 0.006
  31. A Naturalistic, Randomized Pilot Trial of E-Cigarettes: Uptake, Exposure, and Behavioral Effects. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1795-1803.
    View in: PubMed
    Score: 0.006
  32. Effect of a Brief Memory Updating Intervention on Smoking Behavior: A Randomized Clinical Trial. JAMA Psychiatry. 2017 Mar 01; 74(3):214-223.
    View in: PubMed
    Score: 0.005
  33. Deficits in autonomic indices of emotion regulation and reward processing associated with prescription opioid use and misuse. Psychopharmacology (Berl). 2017 Feb; 234(4):621-629.
    View in: PubMed
    Score: 0.005
  34. A Pilot Randomized Crossover Trial of Electronic Cigarette Sampling Among Smokers. Nicotine Tob Res. 2017 Feb; 19(2):176-182.
    View in: PubMed
    Score: 0.005
  35. Burning odor-elicited anxiety in OEF/OIF combat veterans: Inverse relationship to gray matter volume in olfactory cortex. J Psychiatr Res. 2015 Nov; 70:58-66.
    View in: PubMed
    Score: 0.005
  36. Effects of experimental negative affect manipulations on ad libitum smoking: a meta-analysis. Addiction. 2015 May; 110(5):751-60.
    View in: PubMed
    Score: 0.005
  37. The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. Addict Biol. 2016 07; 21(4):954-61.
    View in: PubMed
    Score: 0.005
  38. Increased Functional Connectivity in an Insula-Based Network is Associated with Improved Smoking Cessation Outcomes. Neuropsychopharmacology. 2015 Oct; 40(11):2648-56.
    View in: PubMed
    Score: 0.005
  39. Impulsivity and cigarette craving among adolescent daily and occasional smokers. Addict Behav. 2015 Jun; 45:134-8.
    View in: PubMed
    Score: 0.005
  40. Allostatic dysregulation of natural reward processing in prescription opioid misuse: autonomic and attentional evidence. Biol Psychol. 2015 Feb; 105:124-9.
    View in: PubMed
    Score: 0.005
  41. Neural biomarkers for assessing different types of imagery in pictorial health warning labels for cigarette packaging: a cross-sectional study. BMJ Open. 2014 Dec 31; 4(12):e006411.
    View in: PubMed
    Score: 0.005
  42. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT. J Behav Med. 2015 Apr; 38(2):327-36.
    View in: PubMed
    Score: 0.005
  43. Smoking automaticity and tolerance moderate brain activation during explore-exploit behavior. Psychiatry Res. 2014 Dec 30; 224(3):254-61.
    View in: PubMed
    Score: 0.005
  44. An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):52-6.
    View in: PubMed
    Score: 0.004
  45. Nicotine and non-nicotine smoking factors differentially modulate craving, withdrawal and cerebral blood flow as measured with arterial spin labeling. Neuropsychopharmacology. 2014 Nov; 39(12):2750-9.
    View in: PubMed
    Score: 0.004
  46. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity. Psychopharmacology (Berl). 2014 Aug; 231(16):3229-38.
    View in: PubMed
    Score: 0.004
  47. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. J Consult Clin Psychol. 2014 Jun; 82(3):448-459.
    View in: PubMed
    Score: 0.004
  48. The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev. 2013 Dec; 37(10 Pt 2):2597-607.
    View in: PubMed
    Score: 0.004
  49. Smoker-nonsmoker differences in neural response to smoking-related and affective cues: an fMRI investigation. Psychiatry Res. 2013 Jan 30; 211(1):85-7.
    View in: PubMed
    Score: 0.004
  50. Neural mechanisms of subclinical depressive symptoms in women: a pilot functional brain imaging study. BMC Psychiatry. 2012 Sep 21; 12:152.
    View in: PubMed
    Score: 0.004
  51. Attentional bias for prescription opioid cues among opioid dependent chronic pain patients. J Behav Med. 2013 Dec; 36(6):611-20.
    View in: PubMed
    Score: 0.004
  52. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol Psychiatry. 2011 Oct 15; 70(8):794-799.
    View in: PubMed
    Score: 0.004
  53. Smoking withdrawal shifts the spatiotemporal dynamics of neurocognition. Addict Biol. 2010 Oct; 15(4):480-90.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.